MedPath

Effect of topical tranexamic acid in control of urinary bleeding

Phase 2
Conditions
Haematuria.
Unspecified haematuria
Registration Number
IRCT2014072118545N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion criteria : (patient over 40 years old; lower urinary system bleeding like clot or fresh blood).
Exclusion criteria : (pregnancy; lactation; history of thrombosis or thromboemboli; coagulopathy; history of myocardial infarction or ischemic stroke; renal failure; urinary tract infarction; disagreement to contribute to research)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Haematuria. Timepoint: 0,1,3, and 24 hours. Method of measurement: Urinary test tape.
Secondary Outcome Measures
NameTimeMethod
Haemoglobin. Timepoint: 0, 6, and 24 hours. Method of measurement: CBC Analysis.
© Copyright 2025. All Rights Reserved by MedPath